Imperial College London

Dr Nick Powell

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Clinical Reader in Gastroenterology
 
 
 
//

Contact

 

nicholas.powell

 
 
//

Location

 

Norfolk PlaceSt Mary's Campus

//

Summary

 

Summary

Nick is a Clinical Reader and consultant in Gastroenterology. His key clinical and research interests focus on intestinal inflammation in the context of inflammatory bowel diseases (such as ulcerative colitis and Crohn’s disease), but also in gut inflammation resulting from certain treatments, such as immune checkpoint inhibitors.     

His research group focuses on the molecular and cellular mechanisms responsible for mediating chronic intestinal inflammation, and understanding the dialogue between intestinal microbes and host immunity. His lab is also interested in understanding how cell-specific and tissue-specific transcriptional programmes, including cytokine-responsive networks, disclose important information about disease pathogenesis, and how these "molecular signatures" can be harnessed to predict patient outcomes.

He was previously awarded a Wellcome Trust Intermediate Clinical Fellowship (2013-2019).  He completed specialist registrar training in gastroenterology and internal medicine in London (Hammersmith, St Mary’s). He has also been awarded an MSc (Imperial College London) and PhD in immunology (King’s College London). Major funding has been awarded by the Wellcome Trust, MRC and Crohn’s and Colitis UK. Some key publications include; Powell N, et al. Gastroenterology (2015); 149:456-467, Goldberg R, et al. Nature Reviews in Gastroenterology and Hepatology (2015); 12:271-283, Powell N, et al. Immunity (2012); 37:674-84.   

Publications

Journals

Chanchlani N, Lin S, Chee D, et al., 2021, Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients., J Crohns Colitis

Alexander J, Ibraheim H, Sheth B, et al., 2021, Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor induced enterocolitis treated with infliximab, Journal for Immunotherapy of Cancer, Vol:9, ISSN:2051-1426, Pages:1-9

Alexander J, Powell N, 2021, SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?, The Lancet Gastroenterology and Hepatology, Vol:6, ISSN:2468-1253, Pages:528-529

Hopkins CWP, Powell N, Norton C, et al., 2021, Cognitive Impairment in Adult Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis, Journal of the Academy of Consultation-liaison Psychiatry, Vol:62, ISSN:2667-2960, Pages:387-403

Alexander JL, Powell N, 2021, SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?, Lancet Gastroenterology & Hepatology, Vol:6, Pages:S28-S29

More Publications